APA

Benucci M., Meacci F., Grossi V., Infantino M., Manfredi M., Bellio E., Bellio V., Li Gobbi F., Bazzichi L., Moscato P., Caputo D., Saviola G., Talotta R., Sarzi-Puttini P. & Atzeni F. (20160404). Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab. : Biologics : targets & therapy.

Chicago

Benucci Maurizio, Meacci Francesca, Grossi Valentina, Infantino Maria, Manfredi Mariangela, Bellio Emanuele, Bellio Valerio, Li Gobbi Francesca, Bazzichi Laura, Moscato Paolo, Caputo Dario, Saviola Gianantonio, Talotta Rossella, Sarzi-Puttini Piercarlo and Atzeni Fabiola. 20160404. Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab. : Biologics : targets & therapy.

Harvard

Benucci M., Meacci F., Grossi V., Infantino M., Manfredi M., Bellio E., Bellio V., Li Gobbi F., Bazzichi L., Moscato P., Caputo D., Saviola G., Talotta R., Sarzi-Puttini P. and Atzeni F. (20160404). Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab. : Biologics : targets & therapy.

MLA

Benucci Maurizio, Meacci Francesca, Grossi Valentina, Infantino Maria, Manfredi Mariangela, Bellio Emanuele, Bellio Valerio, Li Gobbi Francesca, Bazzichi Laura, Moscato Paolo, Caputo Dario, Saviola Gianantonio, Talotta Rossella, Sarzi-Puttini Piercarlo and Atzeni Fabiola. Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab. : Biologics : targets & therapy. 20160404.